期刊文献+

麻黄附子细辛汤合桃红四物汤加味治疗类风湿性关节炎30例临床观察 被引量:3

30 Cases of Clinical Observation on Modified Mahuang Fuzi Xixin Decoction and Taohong Siwu Decoction in the Treatment of Rheumatoid Arthritis
下载PDF
导出
摘要 目的:观察麻黄附子细辛汤合桃红四物汤加味治疗类风湿性关节炎的临床效果.方法:选取60例类风湿性关节炎患者随机分为对照组和研究组,每组各30例.对照组给予甲氨蝶呤片治疗,研究组在此基础上,加用麻黄附子细辛汤合桃红四物汤加味治疗,治疗周期为12周,治疗结束后,依据患者关节疼痛、 麻木等临床症状及血沉、 风湿因子等实验室检查指标水平情况,评定疗效.结果:研究组临床总有效率为90.0%,对照组临床总有效率76.67%,差异具有统计学意义(P<0.05).结论:麻黄附子细辛汤合桃红四物汤加味治疗类风湿性关节炎的疗效显著,值得在临床推广应用. Objective To observe the clinical effect of modified Mahuang Fuzi Xixin Decoction and Taohong Siwu Decoction on rheumatoid arthritis.Methods 60 patients with rheumatoid arthritis were randomly divided into study group and control group,30 cases in each group.The control group was treated with methotrexate tablets.On this basis,the study group was treated with ephedra aconite Asarum Decoction and Taohong Siwu decoction.The treatment period was 12 weeks.After the treatment,the curative effect was evaluated according to the clinical symptoms such as joint pain,numbness,erythrocyte sedimentation rate and rheumatic factor.Results he total clinical effective rate was 90.0%in the study group and 76.67%in the control group.There was significant difference between the two groups(P<0.05).Conclusion Modified Mahuang Fuzi Xixin Decoction and Taohong Siwu Decoction are effective in the treatment of rheumatoid arthritis and worthy of clinical application.
作者 李肖 秦晴 王小帆 雷雨 赵红 LI Xiao;QIN Qing;WANG Xiaofan;LEI Yu;ZHAO Hong(Ya'an Traditional Chinese Medicine Hospital,Ya'an 625000,China;Zigong Traditional Chinese Medicine Hospital,Zigong 643010,China;Nanchong Hospital of Traditional Chinese Medicine,Nanchong 637000,China)
出处 《中国民族民间医药》 2019年第13期110-112,共3页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 类风湿性关节炎 麻黄附子细辛汤 桃红四物汤 临床疗效 Rheumatoid Arthritis Mahuang Fuzi Xixin Decoction Taohong Siwu Decoction Clinical EfficacyLiang Xiuyun
  • 相关文献

参考文献6

二级参考文献59

  • 1卢心宇.中药离子导入治疗膝骨性关节炎33例临床观察[J].福建中医药大学学报,2013,23(6):51-53. 被引量:19
  • 2王峰.中药外用治疗膝关节骨性关节炎的临床观察[J].安徽中医学院学报,2004,23(5):8-10. 被引量:25
  • 3贺宪,高凌光,魏春山,陈孝银,王德就.关节镜术加益气补肾行血汤治疗膝骨性关节炎疗效观察[J].中国骨伤,2005,18(8):449-451. 被引量:1
  • 4St Clair EW;Pisetsky DS;Haynes BF;王吉波; 吕振华.类风湿关节炎[M]{H}北京:人民卫生出版社,200813-16.
  • 5Aletaha D,Neogi T,silman AJ. 2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initi}Rive[J].{H}ARTHRITIS AND RHEUMATISM,2010,(09):2569-2581.
  • 6Saudan M,Saudan P,Perneger T. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement:a prospective randomised trial[J].{H}JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME,2007,(02):155-159.
  • 7van der Heijde D,Klareskog L,RodriguezValverde V. Comparison of etanercept and methotrexate,alone and combined,in the treatment of rheumatoid arthritis:two-year clinical and radiograhpic results from the TEMPO study,a double-blind,randomized trial[J].{H}ARTHRITIS AND RHEUMATISM,2006,(04):1063-1074.
  • 8van der Heijde D,Klareskog L,LandewP R. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis[J].{H}ARTHRITIS AND RHEUMATISM,2007,(12):3928-3939.
  • 9Horiuchi T,Mitoma H,Harashima S. Transmembrane TNF-alpha:structure,function and interaction with anti-TNF agents[J].{H}Rheumatology(Oxford),2010,(07):1215-1228.
  • 10Maksymowych WP. Update on the treatment of ankylosing spondylitis[J].Ther Clin Risk Manag,2007,(06):1125-1133.

共引文献473

同被引文献30

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部